Online Yoga and Ayurveda Intervention as Tertiary Prevention of Psychological Comorbidities in COVID-19 Survivors: A Randomized Controlled Trial.

IF 1.8 Q4 NEUROSCIENCES

Annals of Neurosciences Pub Date : 2022-10-01 DOI:10.1177/09727531221117623

Rudra Bhandari

{"title":"Online Yoga and Ayurveda Intervention as Tertiary Prevention of Psychological Comorbidities in COVID-19 Survivors: A Randomized Controlled Trial.","authors":"Rudra Bhandari","doi":"10.1177/09727531221117623","DOIUrl":null,"url":null,"abstract":"Background and purpose: About 56% of symptomatic COVID-19 survivors have been found with neuropsychological comorbidities, such as depression, anxiety, posttraumatic stress disorders (PTSD), and impaired quality of life (QoL). Alongside, antimicrobial, anti-inflammatory, neuroprotective, regenerative, immunomodulatory, cardio-pulmonary health promotive, and psychological benefits of yogic and Ayurvedic intervention are well documented. Therefore, this study aimed to assess the effect of online Yoga (OYI) and Yoga cum Ayurveda intervention (OYAI) on COVID-19-induced depression, anxiety, PTSD, and poor QoL.Method: Seventy-two participants (males/females: 33/26) with at least a 3-month back history of symptomatic COVID-19 infection and age (mean ± SD: 32.33 ± 9.9 and 33.04 ± 12.9 for males and females, respectively) were recruited from Patanjali Ayurveda Hospital, Haridwar, India, and All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India, before random allocation into an equal-sized control group (CG), Yoga group (YG) and Yoga cum concoction (YCG) group. Split-plot analysis of variance and Kruskal-Wallis tests with Bonferroni adjusted post hoc comparisons were computed for normal and nonnormal data using IBM SPSS (25th Version, SPSS South Asia Private Limited, Bangalore, India).Results: Both the treatments-the 30-day OYI and OYAI, significantly improved depression (P < .002, ES: -0.99 and P < .001, ES: -2.11), anxiety (P < .001, ES: -1.32 and -1.89), PTSD (P < .001, ES: -1.8 and -1.83) and QoL related constructs (P < .001, ES: 0.63 and 0.76; 0.71 and 0.93 for each OYI and OYAI versus general health and physical health; P < .001, ES: 0.65 for OYAI versus psychological health; and P < .003, ES: 0.54 for OYI versus environment) of the participants compared to the controls.Conclusion: OYAI may better ameliorate COVID-19-induced psychological comorbidities than OYI with no adverse effects.","PeriodicalId":7921,"journal":{"name":"Annals of Neurosciences","volume":"29 4","pages":"233-244"},"PeriodicalIF":1.8000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/a1/10.1177_09727531221117623.PMC10101154.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Neurosciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/09727531221117623","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}

引用次数: 1

Abstract

Background and purpose: About 56% of symptomatic COVID-19 survivors have been found with neuropsychological comorbidities, such as depression, anxiety, posttraumatic stress disorders (PTSD), and impaired quality of life (QoL). Alongside, antimicrobial, anti-inflammatory, neuroprotective, regenerative, immunomodulatory, cardio-pulmonary health promotive, and psychological benefits of yogic and Ayurvedic intervention are well documented. Therefore, this study aimed to assess the effect of online Yoga (OYI) and Yoga cum Ayurveda intervention (OYAI) on COVID-19-induced depression, anxiety, PTSD, and poor QoL.

Method: Seventy-two participants (males/females: 33/26) with at least a 3-month back history of symptomatic COVID-19 infection and age (mean ± SD: 32.33 ± 9.9 and 33.04 ± 12.9 for males and females, respectively) were recruited from Patanjali Ayurveda Hospital, Haridwar, India, and All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India, before random allocation into an equal-sized control group (CG), Yoga group (YG) and Yoga cum concoction (YCG) group. Split-plot analysis of variance and Kruskal-Wallis tests with Bonferroni adjusted post hoc comparisons were computed for normal and nonnormal data using IBM SPSS (25th Version, SPSS South Asia Private Limited, Bangalore, India).

Results: Both the treatments-the 30-day OYI and OYAI, significantly improved depression (P < .002, ES: -0.99 and P < .001, ES: -2.11), anxiety (P < .001, ES: -1.32 and -1.89), PTSD (P < .001, ES: -1.8 and -1.83) and QoL related constructs (P < .001, ES: 0.63 and 0.76; 0.71 and 0.93 for each OYI and OYAI versus general health and physical health; P < .001, ES: 0.65 for OYAI versus psychological health; and P < .003, ES: 0.54 for OYI versus environment) of the participants compared to the controls.

Conclusion: OYAI may better ameliorate COVID-19-induced psychological comorbidities than OYI with no adverse effects.

Abstract Image

查看原文本刊更多论文

在线瑜伽和阿育吠陀干预作为COVID-19幸存者心理合并症的三级预防:一项随机对照试验

背景和目的:约56%的有症状的COVID-19幸存者被发现患有神经心理合并症，如抑郁、焦虑、创伤后应激障碍(PTSD)和生活质量受损(QoL)。此外，抗微生物、抗炎、神经保护、再生、免疫调节、促进心肺健康以及瑜伽和阿育吠陀干预的心理益处也得到了很好的证明。因此，本研究旨在评估在线瑜伽(OYI)和瑜伽与阿育吠陀干预(OYAI)对covid -19诱导的抑郁、焦虑、创伤后应激障碍和不良生活质量的影响。方法:从印度哈里德瓦尔的帕坦伽利阿育吠陀医院和印度北阿坎德邦里希凯什的全印度医学科学研究所招募了72名至少有3个月症状性COVID-19感染史和年龄的参与者(男/女:33/26)(平均±SD分别为32.33±9.9和33.04±12.9)，然后随机分为等量对照组(CG)、瑜伽组(YG)和瑜伽混合剂组(YCG)。使用IBM SPSS(第25版，SPSS南亚私人有限公司，班加罗尔，印度)计算正态和非正态数据的分裂图方差分析和经Bonferroni调整后的Kruskal-Wallis检验。结果:30天OYI和oai治疗均显著改善抑郁(P < 002, ES: -0.99和P < 0.001, ES: -2.11)、焦虑(P < 0.001, ES: -1.32和-1.89)、创伤后应激障碍(P < 0.001, ES: -1.8和-1.83)和生活质量相关结构(P < 0.001, ES: 0.63和0.76;总体健康和身体健康的OYI和oai分别为0.71和0.93;与心理健康的比较，P < 0.001, ES: 0.65;P < 0.003, ES: 0.54 (OYI vs .环境)。结论:与OYI相比，oai可更好地改善covid -19诱导的心理合并症，且无不良反应。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Neurosciences NEUROSCIENCES-

CiteScore

2.40

自引率

0.00%

发文量